The neuropathology of Alzheimer's disease: a review with pathogenetic, aetiological and therapeutic considerations.

No abstract is available for this paper.

• Publication year

  1985

• Venue

  Mechanisms of Ageing and Development

• Publication date

  1985-09-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/0047-6374(85)90092-2PMID 3906293
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• HLA antigens in Alzheimer's disease.

  2008cited by this paper
• Pathological evidence for neurotransmitter deficits in Down's syndrome of middle age.

  2008cited by this paper
• HLA antigens in Parkinson's disease.

  2008cited by this paper
• Ultrastructure of Hirano bodies

  2004cited by this paper
• Paternal age and Down's syndrome data from prenatal diagnoses (DFG)

  2004cited by this paper
• Ultrastructural study of enriched fractions of “tangles” from human patients with senile dementia of the Alzheimer type

  2004cited by this paper
• Substructures of paired helical filaments from alzheimer's disease neurofibrillary tangles

  2004cited by this paper
• Thickening of the basement membrane of cortical capillaries in Alzheimer's disease

  2004cited by this paper
• Intranuclear inclusions in the neurons of senescent rats

  2004cited by this paper
• Alzheimer paired helical filaments: Immunochemical identification of polypeptides

  2004cited by this paper
• Intranuclear aluminum content in Alzheimer's disease, dialysis encephalopathy, and experimental aluminum encephalopathy

  2004cited by this paper
• Neurological disease and herpes simplex virus

  2004cited by this paper
• Is silica involved in neuritic (senile) plaque formation?

  2004cited by this paper
• Alzheimer paired helical filaments: Bulk isolation, solubility, and protein composition

  2004cited by this paper
• A study of rod-like structures (Hirano bodies) in 240 normal and pathological brains

  2004cited by this paper
• Loss of neurons in the nucleus basalis of Meynert in Alzheimer's disease, paralysis agitans and Korsakoff's disease

  2004cited by this paper
• An immunocytochemical study of intraneuronal inclusions of the caudate and substantia nigra. Reaction with an anti-actin antiserum

  2004cited by this paper
• Relationship between pigment accumulation and age in Alzheimer's disease and Down syndrome

  2004cited by this paper
• Alzheimer's disease: a correlative study.

  1986cited by this paper
• Loss of nerve cells from locus coeruleus in Alzheimer's disease is topographically arranged.

  1986cited by this paper
• Changes in Alzheimer's disease in the magnocellular neurones of the supraoptic and paraventricular nuclei of the hypothalamus and their relationship to the noradrenergic deficit.

  1985cited by this paper
• Neuronal loss in different parts of the nucleus basalis is related to neuritic plaque formation in cortical target areas in Alzheimer's disease.

  1985cited by this paper
• Some morphometric observations on the cerebral cortex and hippocampus in presenile Alzheimer's disease, senile dementia of Alzheimer type and Down's syndrome in middle age.

  1985cited by this paper
• Correlation between senile plaque and neurofibrillary tangle counts in cerebral cortex and neuronal counts in cortex and subcortical structures in Alzheimer's disease.

  1985cited by this paper
• Olfactory tubercle choline acetyltransferase activity in Alzheimer-type dementia, Down's syndrome and Huntington's chorea.

  1984cited by this paper
• Somatostatinergic neurites in senile plaques of aged non-human primates.

  1984cited by this paper
• Familial Alzheimer Dementia: a prevalent disorder with specific clinical features

  1984cited by this paper
• Nucleus Raphe Dorsalis in Dementia of the Alzheimer Type: Neurofibrillary Changes and Neuronal Packing Density

  1984cited by this paper
• Effect of L-dopa on course of Parkinson's disease.

  1984cited by this paper
• Immunoelectronhistochemical evidence for innervation of brain microvessels by vasopressin-immunoreactive neurons in the rat.

  1984cited by this paper
• Correlation of cortical cholinergic and GABA deficits with quantitative neuropathological findings in senile dementia.

  1984cited by this paper
• 159 IDENTIFICATION OF ALZHEIMER PAIRED HELICAL FILAMENT POLYPEPTIDES WITH MONOCLONAL ANTIBODIES

  1984cited by this paper
• Monoaminergic neurotransmitter systems in presenile Alzheimer's disease and in senile dementia of Alzheimer type.

  1984cited by this paper
• The olfactory bulbs in Alzheimer's disease.

  1984cited by this paper
• Staining for microvascular alkaline phosphatase in thick celloidin sections of nervous tissue: morphometric and pathological applications.

  1984cited by this paper
• The protective influence of the locus ceruleus on the blood‐brain barrier

  1984cited by this paper
• Changes in nerve cells of the nucleus basalis of Meynert in Alzheimer's disease and their relationship to ageing and to the accumulation of lipofuscin pigment.

  1984cited by this paper
• Elevation of neuropeptide Y (NPY) in substantia innominata in Alzheimer's type dementia.

  1984cited by this paper
• Sister chromatid exchanges and cell cycle kinetics in Alzheimer's disease.

  1984cited by this paper
• Aging, Alzheimer's disease, and the cholinergic system of the basal forebrain

  1984cited by this paper
• Alzheimer's disease brain: alterations in RNA levels and in a ribonuclease-inhibitor complex.

  1984cited by this paper
• Striatal dopamine receptors in Alzheimer-type dementia.

  1984cited by this paper
• Correlation between cortical plaque count and neuronal loss in the nucleus basalis in Alzheimer's disease.

  1984cited by this paper
• Herpes simplex virus and Alzheimer's disease: a search for virus DNA by spot hybridisation.

  1984cited by this paper
• Chromatin structure in dementia

  1984cited by this paper
• Serotonin Receptor Changes in Dementia of the Alzheimer Type

  1984cited by this paper
• An immunohistochemical study on cerebral vascular and senile plaque amyloid in Alzheimer’s dementia

  1984cited by this paper
• Loss of pigmented dopamine-β-hydroxylase positive cells from locus coeruleus in senile dementia of alzheimer's type

  1983cited by this paper
• Catecholamines and cholinergic enzymes in pre-senile and senile Alzheimer-type dementia and Down's syndrome.

  1983cited by this paper
• Lecithin in the treatment of Alzheimer's disease.

  1983cited by this paper
• Monoamine metabolism in senile dementia of Alzheimer type.

  1983cited by this paper
• Memory enhancement with oral physostigmine in Alzheimer's disease.

  1983cited by this paper
• Parental age as a risk factor in Alzheimer's disease

  1983cited by this paper
• Biochemical Assessment of Serotonergic and Cholinergic Dysfunction and Cerebral Atrophy in Alzheimer's Disease

  1983cited by this paper
• In Vitro Synthesis of Polypeptides of Moderately Large Size by Poly(A)‐Containing Messenger RNA from Postmortem Human Brain and Mouse Brain

  1983cited by this paper
• Cerebrospinal fluid trace element content in dementia

  1983cited by this paper
• Albumin and immunoglobulin in plasma and cerebrospinal fluid, and blood-cerebrospinal fluid barrier function in patients with dementia of Alzheimer type and multi-infarct dementia.

  1983cited by this paper
• Neurofibrillary Changes in Human Brain: An Immunocytochemical Study with a Neurofilament Antiserum

  1983cited by this paper
• Identical twins with Alzheimer's disease.

  1983cited by this paper
• Monoclonal antibodies distinguish phosphorylated and nonphosphorylated forms of neurofilaments in situ.

  1983cited by this paper
• CSFandplasma vasopressmconcentrations in dementia

  1983cited by this paper
• The locus coeruleus and its possible role in ageing and degenerative disease of the human central nervous system.

  1983cited by this paper
• Lethicin in the Treatment of Alzheimer's Disease

  1983cited by this paper
• Retrograde cell degeneration in the basal nucleus in monkey and man.

  1983cited by this paper
• HLA antigens in Alzheimer's disease.

  1983cited by this paper
• Antibodies to paired helical filaments in Alzheimer's disease do not recognize normal brain proteins

  1983cited by this paper
• The effect of advanced old age on the neurone content of the cerebral cortex. Observations with an automatic image analyser point counting method.

  1983cited by this paper
• Central serotonergic nerves project to the pial vessels of the brain

  1983cited by this paper
• The pathology of the human locus ceruleus.

  1983cited by this paper
• A comparison of clinical features in early- and late-onset primary degenerative dementia. One entity or two?

  1983cited by this paper
• Pathological changes in the nucleus of Meynert in Alzheimer's and Parkinson's diseases.

  1983cited by this paper
• Persistence of cholinergic neurons in the basal nucleus in a brain with senile dementia of the Alzheimer's type demonstrated by immunohistochemical staining for choline acetyltransferase.

  1983cited by this paper
• Serotonin nerve cells in Alzheimer's disease.

  1983cited by this paper
• A family with histologically confirmed Alzheimer's disease.

  1983cited by this paper
• Senile dementia of the Alzheimer type

  1983cited by this paper
• Basal nucleus of Meynert: a neuropathological study in Alzheimer's disease, simple senile dementia, Pick's disease and Huntington's chorea.

  1983cited by this paper
• Neuropeptides in Alzheimer type dementia.

  1983cited by this paper
• The isolation and amino acid composition of senile plaque core protein.

  1983cited by this paper
• The use of life tables and survival analysis in testing genetic hypotheses, with an application to Alzheimer's disease.

  1983cited by this paper
• Inability to deactivate sympathetic nervous system in brainstem infarct patients.

  1983cited by this paper
• THE NUCLEUS BASALIS IN ALZHEIMER'S DISEASE: CELL COUNTS AND CORTICAL BIOCHEMISTRY

  1983cited by this paper
• Effects of naloxone in senile dementia: a double-blind trial.

  1983cited by this paper
• Biochemical evidence for cholinergic innervation of intracerebral blood vessels.

  1983cited by this paper
• The distribution of neocortical projection neurons in the locus coeruleus

  1983cited by this paper
• Cortical neuronal counts in normal elderly controls and demented patients.

  1983cited by this paper
• FORM AND DISTRIBUTION OF SENILE PLAQUES SEEN IN SILVER IMPREGNATED SECTIONS IN THE BRAINS OF INTELLECTUALLY NORMAL ELDERLY PEOPLE AND PEOPLE WITH ALZHEIMER‐TYPE DEMENTIA

  1983cited by this paper
• “Limbic Predilection in Alzheimer Dementia: Is Reactivated Herpesvirus Involved?”

  1982cited by this paper
• Plaques, tangles and dementia. A quantitative study.

  1982cited by this paper
• Evidence for Blood‐Brain Barrier Changes in Senile Dementia of the Alzheimer Type (SDAT)

  1982cited by this paper
• Senile dementia of Alzheimer type: Astroglial reaction to extracellular neurofibrillary tangles in the hippocampus

  1982cited by this paper
• Extensive loss of choline acetyltransferase activity is not reflected by neuronal loss in the nucleus of Meynert in Alzheimer's disease.

  1982cited by this paper
• NEURONAL AND LYMPHOCYTIC POPULATIONS IN HUMAN TRIGEMINAL GANGLIA: IMPLICATIONS FOR AGEING AND FOR LATENT VIRUS

  1982cited by this paper
• Viruses and Alzheimer's disease.

  1982cited by this paper
• Monoclonal antibodies show that neurofibrillary tangles and neurofilaments share antigenic determinants

  1982cited by this paper
• Neuronal Lipofuscin Accumulation in Ageing and Alzheimer Dementia: A Pathogenic Mechanism?

  1982cited by this paper
• Cholinergic innervation in neuritic plaques.

  1982cited by this paper
• Lecithin administration in Alzheimer dementia

  1982cited by this paper
• The noradrenergic system in Alzheimer and multi-infarct dementias.

  1982cited by this paper
• Immunostaining of neurofibrillary tangles in Alzheimer's senile dementia with a neurofilament antiserum

  1982cited by this paper
• Alzheimer's disease. Correlation of cortical choline acetyltransferase activity with the severity of dementia and histological abnormalities.

  1982cited by this paper

• Deciphering Alzheimer’s disease transcriptomics: exploration and validation of core genes in tau and Aβ pathological models toward novel therapeutic targets

  2025cites this paper
• Biomarkers for Alzheimer's disease are upregulated in patients with diabetic retinopathy

  2025cites this paper
• A scoping review of magnetic resonance angiography and perfusion image synthesis

  2024cites this paper
• A Scoping Review of Alzheimers Disease Hypotheses: An Array of Uni- and Multi-Factorial Theories

  2024cites this paper
• The Effects of Ninjinyoeito on Impaired Spatial Memory and Prefrontal Cortical Synaptic Plasticity through α-Amino-3-hydroxy-5-4-isoxazole Propionic Acid Receptor Subunit in a Rat Model with Cerebral Ischemia and β-Amyloid Injection

  2023cites this paper
• Microglia-Astrocyte Communication in Alzheimer’s Disease

  2023cites this paper
• Functional Foods: An Approach to Modulate Molecular Mechanisms of Alzheimer’s Disease

  2020cites this paper
• The Neuropeptide Kyotorphin as a Possible Biomarker and Neuroprotective Agent in Alzheimer’s Disease

  2020cites this paper
• Redox signaling in the pathogenesis of human disease and the regulatory role of autophagy.

  2020cites this paper
• Structural and mechanistic insights into the inhibition of amyloid-β aggregation by Aβ39-42 fragment derived synthetic peptides.

  2020cites this paper
• The Full Spectrum of Alzheimer's Disease Is Rooted in Metabolic Derangements That Drive Type 3 Diabetes.

  2019cites this paper
• The Role of Pericytes in Amyotrophic Lateral Sclerosis.

  2019cites this paper
• Risk factors for Alzheimer's disease.

  2019cites this paper
• Improving the Detection Limit of Tau Aggregates for Use with Biological Samples

  2018cites this paper
• Neuropathology of Alzheimer’s disease in Down syndrome

  2018cites this paper
• Effect of running exercise on the number of the neurons in the hippocampus of young transgenic APP/PS1 mice.

  2018cites this paper
• A review of comparison on efficacy, safety and cost effectiveness of cholinesterase inhibitors, NMDA antagonists and combination therapy in the treatment of Alzheimer’s disease

  2018cites this paper
• University of Groningen Formation of Cerebrovascular Anomalies in the Ageing Rat is Delayed by Chronic Nimodipine Application

  2017cites this paper
• Neurofibrillary Tangles of Aβx-40 in Alzheimer’s Disease Brains

  2017cites this paper
• Differences Between Early- and Late-Onset Alzheimer Disease and Stability During the Course of Disease

  2017cites this paper
• An EEG-Based Fuzzy Probability Model for Early Diagnosis of Alzheimer’s Disease

  2016cites this paper
• Advanced Neuroimaging Methods Towards Characterization of Early Stages of Alzheimer's Disease.

  2016cites this paper
• Perilla frutescens Extract Ameliorates Acetylcholinesterase and Trimethyltin Chloride-Induced Neurotoxicity

  2016cites this paper
• Glasgow Coma Scale and the Neurologic Examination

  2016cites this paper
• Oxidative Stress in Alzheimer’s Disease: Should We Keep Trying Antioxidant Therapies?

  2015cites this paper
• ANTI-OXIDANT AND ANTI-BUTYRYLCHOLINESTERASE ACTIVITY OF AN ETHANOLIC EXTRACT OF TINOSPORA CORDIFOLIA . EUROPEAN JOURNAL OF PHARMACEUTICAL AND MEDICAL RESEARCH

  2015cites this paper
• Vascular Factors and the Blood Brain Barrier in Alzheimer’s Disease, Parkinson’s Disease and Amyotrophic Lateral Sclerosis

  2015cites this paper
• Neuron–astrocyte interactions in neurodegenerative diseases: Role of neuroinflammation

  2015cites this paper
• In vivo characterization of the early states of the amyloid-beta network.

  2013cites this paper
• What causes alzheimer's disease?

  2013cites this paper
• Genetic analysis of Down syndrome facilitated by mouse chromosome engineering

  2012cites this paper
• Hippocampal Network Alterations in Alzheimer's Disease and Down Syndrome: From Structure to Therapy

  2011cites this paper
• The 50th anniversary of the discovery of trisomy 21: The past, present, and future of research and treatment of Down syndrome

  2009cites this paper
• L'AGENT ANTICONVULSIVANT VALPROATE STIMULE L'EXPRESSION DE LA PROTÉINE L-ISOASPARTYL MÉTHYLTRANSFÉRASE VIA LA VOIE DE ERK

  2008cites this paper
• Glutamate-glutamine cycling in Alzheimer's disease.

  2007cites this paper
• A novel compound, maltolyl p‐coumarate, attenuates cognitive deficits and shows neuroprotective effects in vitro and in vivo dementia models

  2007cites this paper
• Role for the Peripheral Benzodiazepine Receptor in Neuroinflammation of Neurodegenerative disorders

  2006cites this paper
• Free radical theory of aging: A hypothesis on pathogenesis of senile dementia of the Alzheimer’s type

  2006influential citation
• 192 IgG-Saporin lesions of the nucleus basalis magnocellularis impair serial reversal learning in rats

  2005cites this paper
• Is there a spatial association between senile plaques and neurofibrillary tangles in Alzheimer's disease?

  2005cites this paper
• Alzheimer's disease: areal and laminar pathology in the occipital isocortex

  2004cites this paper
• The identification and characterization of excitotoxic nerve-endings in Alzheimer disease.

  2004cites this paper
• Subcortical afferent projection systems in Huntington's chorea

  2004cites this paper
• The prevalence of amyloid (A4) protein deposits within the cerebral and cerebellar cortex in Down's syndrome and Alzheimer's disease

  2004influential citation
• The identification of pathological subtypes of Alzheimer's disease using cluster analysis

  2004cites this paper
• Neurofibrillary changes confined to the entorhinal region and an abundance of cortical amyloid in cases of presenile and senile dementia

  2004cites this paper
• Neuropathological stageing of Alzheimer-related changes

  2004cites this paper
• Actualización sobre la patología de la enfermedad de Alzheimer

  2002cites this paper
• Mechanisms of Glucocorticoid Actions in Stress and Brain Aging

  2000cites this paper
• Isoaspartate formation and neurodegeneration in Alzheimer's disease.

  2000cites this paper
• Molecular insights into neurodevelopmental and neurodegenerative diseases.

  2000cites this paper
• Glutamate Receptors and Excitotoxic Mechanisms in Alzheimer’s Disease

  1999cites this paper
• Alzheimer's disease and oxidative stress: implications for novel therapeutic approaches.

  1999cites this paper
• Age‐Related Phosphorylation and Fragmentation Events Influence the Distribution Profiles of Distinct Tau Isoforms in Mouse Brain

  1998cites this paper
• Calcium dysregulation in neuronal aging and Alzheimer's disease: history and new directions.

  1998cites this paper
• Amyloid β protein is internalized selectively by hippocampal field CA1 and causes neurons to accumulate amyloidogenic carboxyterminal fragments of the amyloid precursor protein

  1998cites this paper
• Amyloid beta protein is internalized selectively by hippocampal field CA1 and causes neurons to accumulate amyloidogenic carboxyterminal fragments of the amyloid precursor protein.

  1998cites this paper
• Blood‐Cerebrospinal Fluid Barrier Dysfunction for High Molecular Weight Proteins in Alzheimer Disease and Major Depression: Indication for Disease Subsets

  1997cites this paper
• Counting plaques and tangles in Alzheimer's disease: concordance of technicians and pathologists.

  1997cites this paper
• Metals and Oxidative Damage in Neurological Disorders

  1997cites this paper
• Selective cortical and hippocampal volume correlates of Mattis Dementia Rating Scale in Alzheimer disease.

  1997cites this paper
• Aggregation of β‐Amyloid Peptide Is Promoted by Membrane Phospholipid Metabolites Elevated in Alzheimer's Disease Brain

  1997cites this paper
• The Role of Zinc in Brain and Nerve Functions

  1997cites this paper
• Magnetic Resonance Spectroscopic Changes in Alzheimer's Disease a

  1997cites this paper
• Altered pupillary size and darkness and light reflexes in Alzheimer's disease.

  1997cites this paper
• Aggregation of beta-amyloid peptide is promoted by membrane phospholipid metabolites elevated in Alzheimer's disease brain.

  1997cites this paper
• DNA Damage Distribution in the Human Brain as Shown by In Situ End Labeling; Area‐specific Differences in Aging and Alzheimer Disease in the Absence of Apoptotic Morphology

  1997cites this paper
• Observations on the brains of demented old people. B.E. Tomlinson, G. Blessed and M. Roth, Journal of the Neurological Sciences (1970) 11, 205–242; (1968) 7, 331–356

  1997cites this paper
• Cerebrovascular Hypoperfusion: A Risk Factor for Alzheimer's Disease?

  1997cites this paper
• [12] - Magnetic Resonance Spectroscopy of Neural Tissue

  1996cites this paper
• Cerebral vessels in ageing and Alzheimer's disease.

  1996cites this paper
• Quantitative 1H and 31P MRS of PCA extracts of postmortem Alzheimer's disease brain.

  1996cites this paper
• Aluminium and Alzheimer's disease: review of possible pathogenic mechanisms.

  1996cites this paper
• Multiple potential mechanisms of graft action is not a new idea

  1995cites this paper
• Intraretrosplenial grafts of cholinergic neurons and spatial memory function

  1995cites this paper
• Therapeutic neural transplantation: Boon or boondoggle?

  1995cites this paper
• Repairing the brain: Trophic factor or transplant?

  1995cites this paper
• Difficulties inherent in the restoration of dynamically reactive brain systems

  1995cites this paper
• Transplantation, plasticity, and the aging host

  1995cites this paper
• Neural grafting in human disease versus animal models: Cautionary notes

  1995cites this paper
• Studying restoration of brain function with fetal tissue grafts: Optimal models

  1995cites this paper
• Principles of brain tissue engineering

  1995cites this paper
• Induction of non-catalytic TrkB neurotrophin receptors during lesion-induced synaptic rearrangement in the adult rat hippocampus.

  1995cites this paper
• Clinical and neurochemical effects of acetyl-L-carnitine in Alzheimer's disease.

  1995cites this paper
• Models of neurological defects and defects in neurological models

  1995cites this paper
• Building a rational foundation for neural transplantation

  1995cites this paper
• The structure, operation, and functionality of intracerebral grafts

  1995cites this paper
• The NGF superfamily of neurotrophins: Potential treatment for Alzheimer's and Parkinson's disease

  1995cites this paper
• Thinking about repairing thinking

  1995cites this paper
• The spinal cord as an alternative model for nerve tissue graft

  1995cites this paper
• CNS transplant utility may surive even their hasty clinical application

  1995cites this paper
• Neural transplantation, cognitive aging and speech

  1995cites this paper
• Are fetal brain tissue grafts necessary for the treatment of brain damage

  1995cites this paper
• (3H)hemicholinium-3 binding sites in postmortem brains of human patients with Alzheimer's disease and multi-infarct dementia.

  1995cites this paper
• The limitations of central nervous systemdirected gene transfer

  1995cites this paper
• Pathway rewiring with neural transplantation

  1995cites this paper
• Chrysamine-G binding to Alzheimer and control brain: autopsy study of a new amyloid probe.

  1995cites this paper
• Will brain tissue grafts become an important therapy to restore visual function in cerebrally blind patients

  1995cites this paper
• Grafts and the art of mind's reconstruction

  1995cites this paper
• Gene therapy and neural grafting: Keeping the message switched on

  1995cites this paper